Boston Scientific (BSX) Shares Outstanding (Weighted Average) (2009 - 2026)

Boston Scientific has disclosed Shares Outstanding (Weighted Average) across 18 years of filings, most recently posting $1.5 billion for Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $1.5 billion, up 0.52% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.5 billion (up 0.52% YoY), and the FY2025 annual result was $1.5 billion, up 0.6% from the prior year.
• Shares Outstanding (Weighted Average) came in at $1.5 billion for Q1 2026 at Boston Scientific, roughly flat from $1.5 billion in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $1.5 billion in Q1 2026 to a low of $1.4 billion in Q1 2022.
• The 5-year median for Shares Outstanding (Weighted Average) is $1.5 billion (2024), against an average of $1.5 billion.
• Across the five-year window, Shares Outstanding (Weighted Average) climbed 2.27% in 2024 and advanced 0.52% in 2026, its largest moves.
• Boston Scientific's Shares Outstanding (Weighted Average) stood at $1.4 billion in 2022, then increased by 1.57% to $1.5 billion in 2023, then increased by 1.27% to $1.5 billion in 2024, then climbed by 0.6% to $1.5 billion in 2025, then advanced by 0.3% to $1.5 billion in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $1.5 billion (Q1 2026), $1.5 billion (Q4 2025), and $1.5 billion (Q3 2025), per Business Quant data.